Global Point-of-Care Glucose Testing Market Size, Share And Growth Analysis For 2024-2033

LONDON, GREATER LONDON, UK, July 9, 2024 /EINPresswire.com/ -- The global point-of-care glucose testing market is projected to grow from $4.63 billion in 2023 to $4.88 billion in 2024, at a CAGR of 5.4%. The market is anticipated to reach $5.99 billion by 2028, driven by the expansion of telemedicine services, growing emphasis on personalized medicine in diabetes care, and increased investment in glucose testing research and development.

Growing Prevalence of Diabetes Drives Market Growth
The growing prevalence of diabetes is expected to propel the growth of the point-of-care glucose testing market. Diabetes is a chronic metabolic disorder that elevates blood glucose levels, leading to severe damage to various organs. Point-of-care glucose testing enables prompt treatment decisions and enhances diabetes management. For instance, in 2022, the Centers for Disease Control and Prevention reported that around 37.3 million people in the U.S. have diabetes. Additionally, the International Diabetes Federation projects an increase in the global diabetic population from 643 million in 2030 to 783 million by 2045.

Explore comprehensive insights into the global point-of-care glucose testing market with a detailed sample report: https://www.thebusinessresearchcompany.com/sample_request?id=12207&type=smp

Key Players and Market Trends
Major companies operating in the point-of-care glucose testing market include F Hoffmann-La Roche Ltd., Abbott Laboratories Inc., Danaher Corporation, Siemens Healthineers, Becton, Dickinson and Company, TaiDoc Technology Corporation, B. Braun Melsungen AG, Beckman Coulter Inc., Nipro Corporation, Dexcom Inc., Bio-Rad Laboratories Inc., LifeScan Inc., Nova Biomedical Corporation, Ypsomed AG, Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Radiometer Medical ApS, HemoCue AB, EKF Diagnostics Holdings PLC, Trinity Biotech PLC, Bionime Corporation, PTS Diagnostics, ForaCare Inc., Menarini Diagnostics, ACON Laboratories Inc., Senseonics Holdings Inc., Prodigy Diabetes Care LLC, Nemaura Medical Inc., Bluedrop Medical Limited.

Trends: Development of Innovative Glucose Monitoring Solutions
Companies in the point-of-care glucose testing market are focusing on developing innovative solutions such as glucose-ketone monitoring sensors. For example, in June 2022, Abbott Laboratories announced the development of a biowearable sensor system for continuous monitoring of glucose and ketones in diabetic patients. This sensor system, which received breakthrough device designation from the U.S. FDA, is set to become the most compact and slender monitoring device globally, integrating seamlessly with Abbott's digital ecosystem for remote monitoring by healthcare professionals.

Segments:
•Product: Lancet And Lancing Devices, Strips, Meters
•Testing Site: Fingertips, Alternate Site Testing
•Applications: Type-1 Diabetes, Type-2 Diabetes
•End-User: Professional Diagnostic Centers, Hospitals And Clinics, Home Care Settings, Other End Users

Geographical Insights: North America Leading the Market
North America was the largest region in the point-of-care glucose testing market in 2023. The regions covered in the report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Order your report now for swift delivery:
https://www.thebusinessresearchcompany.com/report/point-of-care-glucose-testing-global-market-report

Point-Of-Care Glucose Testing Global Market Report 2024 from TBRC covers the following information:
•Market size data for the forecast period: Historical and Future
•Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
•Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Point-Of-Care Glucose Testing Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on point-of-care glucose testing market size, point-of-care glucose testing market drivers and trends, point-of-care glucose testing market major players, competitors' revenues, market positioning, and market growth across geographies. The point-of-care glucose testing market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Point-Of-Care Diagnostics Devices And Equipment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-devices-and-equipment-global-market-report

Point-Of-Care Molecular Diagnostics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/point-of-care-molecular-diagnostics-global-market-report

Blood Glucose Meters Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report

About The Business Research Company
The Business Research Company has published over 27 industries, spanning over 8000+ markets and 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
X
LinkedIn